These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27473112)

  • 1. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study.
    Liu X; Shen Y; Li Z; Fei A; Wang H; Ge Q; Pan S
    BMC Anesthesiol; 2016 Jul; 16(1):46. PubMed ID: 27473112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
    Giamarellos-Bourboulis EJ; Norrby-Teglund A; Mylona V; Savva A; Tsangaris I; Dimopoulou I; Mouktaroudi M; Raftogiannis M; Georgitsi M; Linnér A; Adamis G; Antonopoulou A; Apostolidou E; Chrisofos M; Katsenos C; Koutelidakis I; Kotzampassi K; Koratzanis G; Koupetori M; Kritselis I; Lymberopoulou K; Mandragos K; Marioli A; Sundén-Cullberg J; Mega A; Prekates A; Routsi C; Gogos C; Treutiger CJ; Armaganidis A; Dimopoulos G
    Crit Care; 2012 Aug; 16(4):R149. PubMed ID: 22873681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
    Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
    Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
    Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
    J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management.
    Zhao L; Yu S; Wang L; Zhang X; Hou J; Li X
    Scand J Clin Lab Invest; 2021 Oct; 81(6):488-493. PubMed ID: 34369213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
    Reisinger AC; Niedrist T; Posch F; Hatzl S; Hackl G; Prattes J; Schilcher G; Meißl AM; Raggam RB; Herrmann M; Eller P
    Sci Rep; 2021 Sep; 11(1):17476. PubMed ID: 34471146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.
    Geboers DG; de Beer FM; Tuip-de Boer AM; van der Poll T; Horn J; Cremer OL; Bonten MJ; Ong DS; Schultz MJ; Bos LD
    Intensive Care Med; 2015 Jul; 41(7):1281-90. PubMed ID: 26100127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can We Improve Mortality Prediction in Patients with Sepsis in the Emergency Department?
    Luka S; Golea A; Vesa ȘC; Leahu CE; Zăgănescu R; Ionescu D
    Medicina (Kaunas); 2024 Aug; 60(8):. PubMed ID: 39202614
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
    El-Mekkawy MS; Saleh NY; Sonbol AA
    Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. suPAR in the assessment of post intensive care unit prognosis: a pilot study.
    Silvestre J; Coelho L; Pereira JG; Mendes V; Tapadinhas C; Póvoa P
    Rev Bras Ter Intensiva; 2018; 30(4):453-459. PubMed ID: 30652779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
    Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
    Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the Circulating Supar Levels with Inflammation, Fibrinolysis, and Outcome in Severe Burn Patients.
    Lin JC; Chen XD; Xu ZR; Zheng LW; Chen ZH
    Shock; 2021 Dec; 56(6):948-955. PubMed ID: 34779798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality.
    Chen D; Wu X; Yang J; Yu L
    Exp Ther Med; 2019 Oct; 18(4):2984-2992. PubMed ID: 31555383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study.
    Haupt TH; Petersen J; Ellekilde G; Klausen HH; Thorball CW; Eugen-Olsen J; Andersen O
    Crit Care; 2012 Jul; 16(4):R130. PubMed ID: 22824423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
    Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
    Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombo-inflammatory biomarkers to predict sepsis outcome.
    Efat A; Shoeib SA; Arafa AF; Dawod AA; Abd ElHafez MA; Abd ElMohsen EA; Eladly HF; Ibrahim RA; Elkholy A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048561. PubMed ID: 34647483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.